Yoshitaka Sekido

19.5k total citations · 3 hit papers
199 papers, 14.3k citations indexed

About

Yoshitaka Sekido is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yoshitaka Sekido has authored 199 papers receiving a total of 14.3k indexed citations (citations by other indexed papers that have themselves been cited), including 125 papers in Molecular Biology, 70 papers in Pulmonary and Respiratory Medicine and 54 papers in Oncology. Recurrent topics in Yoshitaka Sekido's work include Occupational and environmental lung diseases (36 papers), RNA modifications and cancer (36 papers) and Hippo pathway signaling and YAP/TAZ (27 papers). Yoshitaka Sekido is often cited by papers focused on Occupational and environmental lung diseases (36 papers), RNA modifications and cancer (36 papers) and Hippo pathway signaling and YAP/TAZ (27 papers). Yoshitaka Sekido collaborates with scholars based in Japan, United States and Australia. Yoshitaka Sekido's co-authors include John D. Minna, Hirotaka Osada, Yasushi Yatabe, Takashi Takahashi, Kwun M. Fong, Yutaka Kondo, Kaoru Shimokata, Toyoaki Hida, Masashi Kondo and Shuta Tomida and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Yoshitaka Sekido

195 papers receiving 14.1k citations

Hit Papers

A Polycistronic MicroRNA Cluster, miR-17-92 , Is Overexpr... 1998 2026 2007 2016 2005 2001 1998 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Polycistronic MicroRNA Cluster, miR-17-92 , Is Overexpressed in Human Lung Cancers and Enhances Cell Proliferation
    2005 1.3k citations Yoji Hayashita, Hirotaka Osada et al. Cancer Research profile →
  2. Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression
    2001 659 citations Yoshitaka Sekido et al. profile →
  3. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression
    1998 569 citations Yoshitaka Sekido et al. Oncogene profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshitaka Sekido Japan 69 9.3k 3.7k 3.6k 3.3k 1.6k 199 14.3k
W.K. Alfred Yung United States 64 8.1k 0.9× 3.8k 1.0× 2.9k 0.8× 3.2k 1.0× 805 0.5× 175 15.0k
Kenneth J. Hillan United States 36 9.0k 1.0× 4.2k 1.1× 2.5k 0.7× 3.0k 0.9× 1.0k 0.6× 57 14.6k
Edward Gabrielson United States 60 9.9k 1.1× 3.4k 0.9× 1.9k 0.5× 3.1k 0.9× 905 0.6× 135 13.7k
Michael I. Lerman United States 61 10.2k 1.1× 2.6k 0.7× 2.9k 0.8× 4.3k 1.3× 962 0.6× 165 14.5k
Ju‐Seog Lee United States 61 7.9k 0.9× 3.7k 1.0× 2.2k 0.6× 3.9k 1.2× 1.6k 1.0× 218 13.3k
Dean G. Tang United States 66 8.6k 0.9× 5.3k 1.5× 2.5k 0.7× 4.5k 1.4× 1.1k 0.7× 172 14.4k
Gary E. Gallick United States 67 7.7k 0.8× 6.0k 1.6× 2.0k 0.5× 2.9k 0.9× 1.3k 0.8× 202 13.7k
William A. Weiss United States 60 9.3k 1.0× 2.8k 0.8× 1.9k 0.5× 3.7k 1.1× 1.1k 0.6× 268 15.3k
Agnieszka K. Witkiewicz United States 60 7.0k 0.8× 6.5k 1.8× 3.1k 0.8× 5.1k 1.6× 1.5k 0.9× 176 13.6k
Reinhard Buettner Germany 60 8.9k 1.0× 3.4k 0.9× 2.3k 0.6× 2.1k 0.6× 820 0.5× 312 14.3k

Countries citing papers authored by Yoshitaka Sekido

Since Specialization
Citations

This map shows the geographic impact of Yoshitaka Sekido's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshitaka Sekido with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshitaka Sekido more than expected).

Fields of papers citing papers by Yoshitaka Sekido

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshitaka Sekido. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshitaka Sekido. The network helps show where Yoshitaka Sekido may publish in the future.

Co-authorship network of co-authors of Yoshitaka Sekido

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshitaka Sekido. A scholar is included among the top collaborators of Yoshitaka Sekido based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshitaka Sekido. Yoshitaka Sekido is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fennell, Dean A., Yoshitaka Sekido, Paul Baas, et al.. (2025). Pleural mesothelioma. Nature Reviews Disease Primers. 11(1). 56–56.
2.
Sekido, Yoshitaka & Tatsuhiro Sato. (2023). NF2 alteration in mesothelioma. SHILAP Revista de lepidopterología. 5. 1161995–1161995. 17 indexed citations
3.
Sato, Tatsuhiro, Haruna Ikeda, Emi Mishiro‐Sato, et al.. (2021). Silencing of SmgGDS, a Novel mTORC1 Inducer That Binds to RHEBs, Inhibits Malignant Mesothelioma Cell Proliferation. Molecular Cancer Research. 19(5). 921–931. 4 indexed citations
4.
Tomoike, Fumiaki, Yasuaki Kimura, Keiko Kuwata, et al.. (2017). A covalent G-site inhibitor for glutathione S-transferase Pi (GSTP1-1). Chemical Communications. 53(81). 11138–11141. 48 indexed citations
5.
Mizuuchi, Hiroshi, Kenichi Suda, Katsuaki Sato, et al.. (2015). Collateral Chemoresistance to Anti-Microtubule Agents in a Lung Cancer Cell Line with Acquired Resistance to Erlotinib. PLoS ONE. 10(4). e0123901–e0123901. 13 indexed citations
6.
Natsume, Atsushi, Motokazu Ito, Keisuke Katsushima, et al.. (2013). Chromatin Regulator PRC2 Is a Key Regulator of Epigenetic Plasticity in Glioblastoma. Cancer Research. 73(14). 4559–4570. 79 indexed citations
7.
Nakagawa, Takayuki, Shinji Takeuchi, Tadaaki Yamada, et al.. (2013). EGFR-TKI Resistance Due to BIM Polymorphism Can Be Circumvented in Combination with HDAC Inhibition. Cancer Research. 73(8). 2428–2434. 136 indexed citations
8.
Nakagawa, Takayuki, Shinji Takeuchi, Tadaaki Yamada, et al.. (2012). Combined Therapy with Mutant-Selective EGFR Inhibitor and Met Kinase Inhibitor for Overcoming Erlotinib Resistance in EGFR -Mutant Lung Cancer. Molecular Cancer Therapeutics. 11(10). 2149–2157. 74 indexed citations
9.
Tomizawa, Kenji, Kenichi Suda, Ryoichi Onozato, et al.. (2011). Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers. Lung Cancer. 74(1). 139–144. 113 indexed citations
10.
Murakami, Hideki, Tetsuya Mizuno, Tetsuo Taniguchi, et al.. (2011). LATS2 Is a Tumor Suppressor Gene of Malignant Mesothelioma. Cancer Research. 71(3). 873–883. 181 indexed citations
11.
Suda, Kenichi, Isao Murakami, Tatsuya Katayama, et al.. (2010). Reciprocal and Complementary Role of MET Amplification and EGFR T790M Mutation in Acquired Resistance to Kinase Inhibitors in Lung Cancer. Clinical Cancer Research. 16(22). 5489–5498. 170 indexed citations
12.
Yamada, Tadaaki, Kunio Matsumoto, Wei Wang, et al.. (2009). Hepatocyte Growth Factor Reduces Susceptibility to an Irreversible Epidermal Growth Factor Receptor Inhibitor in EGFR -T790M Mutant Lung Cancer. Clinical Cancer Research. 16(1). 174–183. 85 indexed citations
13.
Osada, Hirotaka, Shuta Tomida, Yasushi Yatabe, et al.. (2008). Roles of Achaete-Scute Homologue 1 in DKK1 and E-cadherin Repression and Neuroendocrine Differentiation in Lung Cancer. Cancer Research. 68(6). 1647–1655. 83 indexed citations
14.
Tanaka, Hisaaki, Kiyoshi Yanagisawa, Keiko Shinjo, et al.. (2007). Lineage-Specific Dependency of Lung Adenocarcinomas on the Lung Development Regulator TTF-1. Cancer Research. 67(13). 6007–6011. 165 indexed citations
15.
Horio, Yoshitsugu, Junichi Shimizu, Hirotaka Osada, et al.. (2007). The mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity of cisplatin, carboplatin and gemcitabine in human lung cancer cell lines. Molecular Cancer Therapeutics. 6. 1 indexed citations
16.
Hayashita, Yoji, Hirotaka Osada, Yoshio Tatematsu, et al.. (2005). A Polycistronic MicroRNA Cluster, miR-17-92 , Is Overexpressed in Human Lung Cancers and Enhances Cell Proliferation. Cancer Research. 65(21). 9628–9632. 1274 indexed citations breakdown →
17.
Kajita, Mitsuharu, Yoshitaka Sekido, Satoshi Kikuchi, et al.. (2001). Novel Mutations (H337R and 238–362del) in the <i>CPS1</i> Gene Cause Carbamoyl Phosphate Synthetase I Deficiency. Human Heredity. 52(2). 99–101. 16 indexed citations
18.
Noguchi, Masahiro, Kazuyoshi Imaizumi, Tsutomu Kawabe, et al.. (2001). Induction of antitumor immunity by transduction of CD40 ligand gene and interferon-γ gene into lung cancer. Cancer Gene Therapy. 8(6). 421–429. 23 indexed citations
19.
20.
Sundaresan, Vasi, Grace Chung, Amanda Heppell-Parton, et al.. (1998). Homozygous deletions at 3p12 in breast and lung cancer. Oncogene. 17(13). 1723–1729. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W.K. Alfred Yung Breakdown of academic impact, for papers by Kenneth J. Hillan Breakdown of academic impact, for papers by Edward Gabrielson Breakdown of academic impact, for papers by Michael I. Lerman Breakdown of academic impact, for papers by Ju‐Seog Lee Breakdown of academic impact, for papers by Dean G. Tang Breakdown of academic impact, for papers by Gary E. Gallick Breakdown of academic impact, for papers by William A. Weiss Breakdown of academic impact, for papers by Agnieszka K. Witkiewicz Breakdown of academic impact, for papers by Reinhard Buettner
Rankless by CCL
2026